Shandong Keyuan Pharmaceutical Co., Ltd. (SHE:301281)

China flag China · Delayed Price · Currency is CNY
41.57
+1.60 (4.00%)
At close: May 28, 2026
Market Cap4.50B +39.1%
Revenue (ttm)448.33M +4.6%
Net Income23.54M -62.0%
EPS0.21 -62.9%
Shares Out 108.29M
PE Ratio194.87
Forward PEn/a
Dividend0.05 (0.13%)
Ex-Dividend DateMay 20, 2025
Volume3,576,761
Open39.63
Previous Close39.97
Day's Range39.55 - 41.77
52-Week Range25.87 - 53.99
Beta-0.06
Analystsn/a
Price Targetn/a
Earnings DateAug 14, 2026

About SHE:301281

Shandong Keyuan Pharmaceutical Co., Ltd. is involved in the research and development, manufacture, and marketing of chemical raw materials and their preparations. It offers gliclazide; metformin hydrochloride; isosorbide mononitrate; isosorbide dinitrate; lansoprazole; mecobalamin; ropivacaine hydrochloride; isoflurane; fluoxetine hydrochloride; clemastine fumarate; chlorpheniramine maleate; esmolol hydrochloride; nicotinamide-tinidazole; amlexanox; nisoldipine; qupibutu; clarithromycin lactobionate; propafenone hydrochloride; potassium diclofe... [Read more]

Sector Healthcare
Founded 2004
Employees 650
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301281
Full Company Profile

Financial Performance

In 2025, SHE:301281's revenue was 398.23 million, a decrease of -14.12% compared to the previous year's 463.72 million. Earnings were 16.55 million, a decrease of -72.62%.

Financial Statements